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Summary: A method for the separation and quantification of a complex ganglioside mixture from a clinically
available amount (5 ml) of human cerebrospinal fluid (CSF) is described. After reduction of the CSF volume
by ultrafiltration, gangliosides are extracted with methanol/chloroform, then separated and quantified by high
performance thin layer chromatography (HPTLC) and direct densitometry. For purification of crude gan-
glioside extract, the method of choice was microdialysis against water. Recovery for the present method
including all methodological steps was 78%. No delective loss of gangliosides was demonstrated.
The CSF ganglioside pattern from 'normal' CSF samples resembles that of brain gangliosides, particularly
cerebellum gangliosides. Based on Chromatographie comparison with standards, the percentages of lipid-
bound NeuAc-positive fractions were:
GMI = II3NeuAc-GgOse4Cer (3%),
GD3 - II3NeuAc2-Lac-Cer (3%),
GDla = IV3NeuAc,II3NeuAc-GgOse4Cer(15%),
Xi (3%),
GDlb = II3(NeuAc)2-GgOse4Cer(16%),
X2 (3%),
GTib = IV3NeuAc,II3NeuAc2-GgOse4-Cer (41%), and
GQlb = IV3NeuAc2-,II3NeuAc2-GgOse4-Cer(16%).
The total ganglioside content varied between 616 — 944 μ§/1.
Within-run and between-run assay precision (relative standard deviation) for 'normal' pooled CSF ranged
from 0.04 to 0.12 for the predominant CSF ganglioside fractions (GDia, GDlb, GTn» GQlb), and from 0.13 to
0.23 for the less pronounced fractions (GMi, GD3).
Introduction , ,^ „ „ , , , . , , , .
onstrated (3). So far, only a few published studies
The content of lipids in cerebrospinal fluid (CSF) is have shown that the ganglioside profile of CSF more
very low (1). Gangliosides1) are sialic acid-containing closely resembles that of brain tissue than that of
glycosphingolipids displaying their highest concentra- plasma (4 — 6). However, due to methodological dif-
tions in nervous tissue (2). Their accumulation in CSF ficulties, the gangliosides in normal human CSF were
in lipid storage diseases (gangliosidosis) has been dem- not clearly identified in these previous reports. Quan-
tification of gangliosides in the picomolar range using
*) See page 864. scanning densitometry on high-performance thin-
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layer chromatography (HPTLC) has been reported
(7, 8). The aim of this study was to present a method
suitable for simultaneous profile analysis and gan-
glioside quantification from clinically available
amounts of CSF (5 ml). The method consisted of
ganglioside extraction, separation and quantification,
employing HPTLC on silica gel and scanning densi-
tometry.
Materials and Methods
All reagents were of reagent-grade quality. Solvents were redis-
tilled before used. A commercially available apparatus from
Sartorius GmbH (G ttingen, FRG) and collodium bags SM
13200, were used for ultraflltration. Sephadex G-25 fine was
purchased from Pharmacia Fine Chemicals (Uppsala, Sweden).
Standard dialysis membranes from Technicon Chemicals Co.
(Orcq, Belgium) were used for dialysis. High-performance thin-
layer Chromatographie plates (HPTLC) silica gel 60 (10 χ 10
cm) were purchased from Merck (Darmstadt, FRG). The Cron-
assial ganglioside mixture from Fidia (Abano Terme, Italy),
diluted 1:10 with water (0.5 g per litre of gangliosides) was
used as a standard for the ganglioside HPTLC determination.
Coronassial contains: GMi (21%), GDla (40%), GDlb (16%) and
G™ (19%). Radiolabelled [3H]GDla (1 g/1) was a generous gift
from Dr. G. Schwarzmann, Inst. Organ. Chem. Biochem., Uni-
versity of Bonn (14000 counts/min -5 μg GDia). GM2 ganglioside(bovine) was purchased from Calbiochem. A LKB 2202 Ul-
trascan Laser Densitometer and a 2220 Recording Integrator
(Bromma, Sweden) were used for densitometric analysis.
Lumbar CSFs were obtained from adult patients and children
with various neurological diseases. CSFs from adults free of
any signs of acute inflammatory process of the CNS, tumours,
demyelination, intracranial haemorrhage or congenital errors
of lipid metabolism, were used as 'normals'. After cytological
and biochemical examinations, CSF samples were centrifuged
Designation according to IUPAC-IUB Recommendations
(20).
Ganglioside abbreviations follow the nomenclature system
of L. Svennerholm (19):
Svennerholm (19)* Lipid Document (20)**
II3NeuAc-LacCer
II3NeuAc-GgOse4Cer
IV3NeuAc,II3NeuAc-GgOse4Cer
II3(NeuAc)2-GgOse4Cer
IV3NeuAc,II3(NeuAc)2-GgOse4Cer
IV3(NeuAc)2II3(NeuAc)2-GgOse4Cer
GDlb
GTib
GQlb
* G = ganglioside; M = monosialo; D = disialo; T =
trisialo. Arabic numerals indicate sequence of migration
in thin-layer chromatograms (19).
** Neu Ac = 7V-Acetylneuraminic acid; Lac = lactose;
GgOse4 = gangliotetraose =
Gal( l -3)GalNAc( l -4)Gal( l -4)GlcCer; Cer =
Cer amide.
The location of the NeuAc residue is indicated by a
Roman numeral designating the position of the mono-
saccharide residue in the parent oligosaccharide (counting
from the ceramide end) to which the NeuAc residue is
attached, with an Arabic numeral superscript indicating
the position within that residue to which the NeuAc is
attached (20).
before ganglioside extraction (2000 g, 10 minutes). Pooled 'nor-
mal' CSFs were used for method evaluation and statistical
analysis. Recovery was measured in two ways, i. e. either with
CSF itself using a radiolabelled tracer ([3H]GDla, 5 μg/5 ml
CSF), or by processing the Cronassial ganglioside mixture in
H2O or artificial CSF (7 μg/5 ml CSF art.). Artificial CSF
consisted of CSF ultrafiltrate (5 ml) and serum (20 μΐ). Assay
precision was evaluated by analysing pooled CSF (or Cronassial
added to artificial CSF) twelve times on the same day and on
different days in a period of four mounths. Linearity of the
relationship between densitometric responses (total area) and
ganglioside content was determined by spotting increasing
amounts of gangliosides from diluted Cronassial on HPTLC
plates.
U l t r a f i l t r a t i o n (vacuum dialysis)
Native CSF samples (5 ml) were reduced to about 0.5 ml by
ultraflltration against water, the semipermeable membrane
rinsed with 0.250 ml of 0.077 mol/1 saline and the volume of
the CSF concentrate adjusted to 0.750 ml.
CSF ganglioside ext rac t ion procedure
Gangliosides were extracted from CSF by a slightly modified
method of Svennerholm & Fredman (9). In place of the water
phase, a reduced volume of CSF (concentrate) was used. The
ratio chloroform-methanol-CSF was 1:2:0.75 by volume.
Briefly, 2 ml of methanol were added to 0.75 ml of CSF con-
centrate; after mixing on a cyclomixer, 1 ml of chloroform was
added and mixed again. The gangliosides were separated from
other lipids by phase partition, after the addition of 0.65 ml of
water. The two phases were separated by centrifugation (15 — 20
min, 3000 g), and the upper phase was set aside. For second-
phase partition of the lower phase, 0.380 ml of methanol and
0.250 ml of water were added. The two upper phases were
combined and evaporated to dryness (37 °C).
Al t e rna t ive procedure for CSF ganglioside extrac
tion
Gangliosides were directly extracted from 6 ml of native CSF,
using a solvent ratio of chloroform-methanol-CSF of 8:16:6
by volume. For phase partition, 5.2 ml of water were added.
After overnight separation in a glass funnel, the upper phase
was set aside. For second-phase partition of the lower phase,
3 ml of methanol and 2 ml of water were added. The two upper
phases were combined and evaporated to dryness (37 °C).
Puri f icat ion of crude gangl ioside extract by microdi
alysis
Crude ganglioside extract was dissolved in a few microlitres of
chloroform-methanol-water (60:30:4.5, by volume) and quan-
titatively transferred to a microcup (0.1 ml) for dialysis. After
evaporation of the solvent to dryness, the ganglioside residue
was dissolved in 100 μΐ of water and the microcup covered with
a dialysis membrane. After dialysis against water for about four
hours, the dialysis membrane was pierced with the plastic tip
of a 100 μΐ micropipette, and the ganglioside water extract
quantitatively transferred to a conical tube and evaporated to
dryness.
Al t e rna t ive procedure for pur i f ica t ion of crude gan-
glioside extract by gel f i l t ra t ion on Sephadex G-25.
A modified method of Wells and Dittmer (10)
Crude ganglioside extract was dissolved in chloroform-metha-
nol-water (60:30:4.5, by volume) and applied to a Sephadex
G-25 column (110 χ 5mm, 1.4 ml bed volume, resin mixed
J. Clin. Chem. Clin. Biochem. / Vol. 28,1990 / No. 11
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with the same solvent mixture). The gangliosides were eluted
from the column with 6 — 7 ml of the same solvent mixture.
The column was then eluted with about 1 ml of the second
solvent mixture of chloroform-methanol-water (20:20:7.5, by
volume), and the combined eluates were evaporated to dryness.
High per formance t h i n - l a y e r ch roma tog raphy
(HPTLC)
Gangliosides were separated using the ascending "sandwich"
HPTLC technique (11). Two plastic 1 mm-thick strips were
used as gaskets. Before use, HPTLC plates were pre-washed
with chloroform-methanol (1:1, by volume) and activated at
110 °C during 60 min. The ganglioside extract was dissolved in
a few microlitres of chloroform-methanol-water (60:30:4.5, by
volume) and quantitatively transferred onto a HPTLC plate.
The samples were applied as a line. After formation of a
"sandwich" the following solvent system was used for Chro-
matographie separation of gangliosides: chloroform-methanol-
12 mmol/1 MgCl2 in H2O- 13.3 mol/1 NH3 (60:40:9:0.5, by
volume). Chromatography was performed at 17 —18 °C using
a freshly prepared solvent system. Development was stopped
when the solvent front reached 1 — 1.5 cm from the upper edge
of the plate. After drying the HPTLC plate, the same procedure
was repeated with a fresh solvent mixture.
Densi tometr ic scanning and quan t i f i ca t ion of CSF
gangliosides
For densitometric quantification, three standards of 5, 10 and
15 μΐ of diluted Cronassial (corresponding to 2.5, 5 and 7.5 μg
of gangliosides, respectively) were spotted on the same HPTLC
plate. Gangliosides were visualized on the plate (as lipid-bound
NeuAc) by spraying with resorcinol-HCl reagent diluted with
an equal volume of water (12), and the HPTLC plate was
heated as suggested by Ando et al. (13). Total amounts of CSF
gangliosides were calculated from a calibration curve plotted
from the densitometric response (total area) as a function of
the amount of gangliosides ^g) in standards (Cronassial). The
content of individual ganglioside was calculated from the cali-
bration curve based on an appropriate densitometric response
(area) or from the relative percentage multiplied by the total
content of gangliosides.
Results and Discussion
Procedure of CSF ganglioside extraction
Reduction of the CSF and solvent volumes increased
the recovery and reproducibility of the extraction
method (tab. 1). Ultrafiltration did not result in either
any major loss of total gangliosides (tab. 1) or any
selective loss (tab. 2), although the molecules involved
were those of low molecular mass. The procedure is
based on the assumption that CSF gangliosides are
associated with proteins. Albumin is known to
strongly bind to gangliosides (14). Moreover, a rapid
procedure of CSF volume reduction causes an abrupt
increase in ganglioside concentration, thereby trigger-
ing the formation of micelles of higher molecular mass
(2).
Ultrafiltration also removes large quantities of salts
(especially divalent cations) from the CSF before ex-
traction of the gangliosides (CSF contains about 270
mmol/1 salts and 300 nmol/1 gangliosides). A tendency
of gangliosides to accumulate into a 'ganglioside-
protein-divalent cation complex' at the interface in
the biphasic solvent system has been described (15).
We also investigated whether this ganglioside isolation
procedure, based on the partitioning method, is ap-
plicable in the present CNS pathology where less polar
gangliosides (i.e. GM2 gangliosidosis) are elevated.
About 75% of GM2 was recovered in the upper organic
phase after adding GM2 ganglioside to a CSF sample
(fig. 3e).
In pathological CSF samples with high protein con-
centrations, the concentration of polysialoganglio-
sides, particularly GQlb, is decreased (tab. 3), but a
similar effect was also demonstrated 'in vitro' by
adding serum to CSF samples (tab. 3, fig. 1). A
dramatic decrease in the concentration of polysialo-
gangliosides (GQlb about 75%, GTlb and GDib about
50%) was also observed after the addition of crude
CSF ganglioside extract to serum, as determined by
ganglioside extraction and HPTLC (figs. 3g, f)· In
contrast, a parallel experiment using isolated ganglio-
sides of CSF and serum gave a strictly additive
HPTLC analysis upon mixing (fig. 1). This means
that high protein concentrations markedly interfere
with the extraction of gangliosides. The action of
serum sialidase as a possible cause of the decrease of
ganglioside values was ruled out by replacing serum
with pure albumin solution (fig. 1). Therefore, for the
analysis of pathological CSFs with high protein con-
centration should be reduced less and the volume of
organic solvents proportionally increased, allowing
efficient protein precipitation and ganglioside extrac-
tion. The question remains, however, as to the nature
of the real ganglioside pattern in serum or in other
samples with high protein concentration.
Purif icat ion of crude CSF ganglioside ex-
tract
Microdialysis is a very simple and reproducible
method for crude CSF ganglioside extract purifica-
tion, with good recovery (98%) and no selective loss
of gangliosides (tab. 1). In microdialysis, the CSF
ganglioside extracts were dissolved in the least pos-
sible amount of water (up to 0.1 ml), thus achieving
a ganglioside concentration closely approaching the
critical micellar concentrations (2). Besides, the short
time needed for dialysis (about 4 hours) also avoids
any major loss of gangliosides. Such a brief dialysis
is possible because the CSF samples are desalinated
during the preceding procedure of ultrafiltration.
J. Clin. Chem. Clin. Biochem. / Vol. 28,1990 / No. 11
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Tab. 2. Precision of ganglioside determination in cerebrospinal fluid (CSF)*
GD3
GDla
Xl
GDlb
Cronassial**
Within-run
(n = 12)
HPTLC
Percentage
distribution
(%, mean ± SD)
17.8 ± 1.5
40.9 ± 1.8
15.1 ± 1.3
20.7 ± 1.6
Pooled CSF (5 ml)
Between-run
(n = 12)
HPTLC
Percentage
distribution
(%, mean ± SD)
17.2 ±1.8
40.2 ± 2.1
15.5 ± 1.6
21.2 ±1.8
Within-run
(n = 12)
HPTLC
Percentage
distribution
(%, mean ± SD)
3.2 + 0.4
3.5 ± 0.4
14.8 ± 1
2.9 ± 0.4
15.8 ±1.3
3.5 ± 0.4
40.7 + 1.7
15.6 + 1.5
Amount of
gangliosides
fog/I, mean + SD)
2 5 + 4
2 8 + 4
117+ 8
23+ 3
125 + 10
2 8 + 3
323 + 14
124+ 12
Between-run
(n = 12)
HPTLC
Percentage
distribution
(%, mean + SD)
3.0 + 0.7
3.3 + 0.5
14.3 + 1.2
2.7 + 0.7
16.1 + 1.5
2.9 + 0.7
41.5 + 2.1
16.2 + 1.9
Amount of
gangliosides
fog/I, mean + SD)
24+ 5
2 7 + 4
116+ 10
22+ 5
130 + 12
2 3 + 5
336 + 18
131 + 15
Amount of total CSF gangliosides
calculated from calibration curve
793 + 44 810 + 70
* All methodological steps are included (ultrafiltration, extraction, dialysis and HPTLC)
** Cronassial added to artificial CSF was used (see Material and Methods)
Purification of crude ganglioside extract by gel filtra-
tion on Sephadex G-25 columns is a methodologically
more complex and less reproducible method (tab. 1).
Use of the original procedure of Wells & Dittmer (10)
resulted in delay of trisialo- and tetrasialogangliosides
on Sephadex G-25 (and the absence of GQ2b from the
HPTLC-CSF ganglioside profile). Our modification
of this method by changing the eluent polarity in the
last milliliter results in the elution of GQib and GTib
gangliosides (fig. 2).
HPTLC and quant i f icat ion by scanning den-
sitometry
A high quality chromatogram is a prerequisite for
ganglioside quantification by densitometry. Using the
HCl-resorcinol method for detection of lipid-bound
NeuAc, individual fractions containing about 60 ng
of ganglioside can be detected on HPTLC, if applied
as a 6-mm line (fig. 3).
Linearity of the relationship between the densitome-
tric detector response (total area) and ganglioside
content in standards (Cronassial) was demonstrated
up to 10 g of gangliosides. A calibration curve for
quantification of total CSF gangliosides was designed
within this range.
Mullin et al. (7, 8) have reported that gangliosides
after HPTLC and resorcinol staining produce differ-
ent densitometric detector responses per mol of
NeuAc (different calibration curves), due to differ-
ences in band geometry following migration. In our
"sandwich" HPTLC technique, a lower Chromato-
graphie temperature (17-18°C) without previous
saturation of the TLC chamber with solvent vapour,
and linear application of the sample resulted in gan-
glioside bands of nearly identical size and shape, thus
minimizing the factors that might interfere when
quantitating individual gangliosides within a mixture.
Recovery and precision of CSF ganglioside
determination
Our results revealed an overall loss of about 25% of
gangliosides during various methodological steps (tab.
1). No selective loss of gangliosides was demonstrated
(tab. 2). Assay precision (relative standard deviation),
within-run and between-run, ranged from 0.04 to 0.12
for major fractions (GQib, GTib, GDib, Goia), and from
0.13 to 0.23 for minor fractions (GMi, GD3) (tab. 2).
CSF ganglioside pattern (HPTLC)
Lipid-bound NeuAc-positive fractions in 'normal'
CSF samples were demonstrated in the following re-
gions as defined by standards (%, mean): GMi (3.4%),
GD3 (3.6%), GDla (14.6%), X, (2.5%), GDlb (15.6%),
X2 (3.8%), GTib (40.6%), and GQlb (15.9%) (tab. 3).
The CSF ganglioside profile resembled that of brain
gangliosides, particularly cerebellum gangliosides,
with GTib as a predominant fraction (16). Our results
also showed GDla to.be higher in infancy (tab. 3),
which correlated well with the results obtained on
brain tissue (17). Higher proportions of GM3 and GD3
in pathological CSF ganglioside patterns correlated
with the blood-brain barrier dysfunction (CSF hae-
morrhages, tumour processes), and suggested an in-
creased transport of serum gangliosides into CSF.
J. Clin. Chem. Clin. Biochem. / Vol. 28,1990 / No. 11
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Fig. 2. HPTLC patterns of gangliosides from CSF and brain
after purification of the crude ganglioside extract by the
method of Wells & Dittmer with Sephadex G-25 (A)
and after our modification of this method (C) by chang-
ing effluent polarity in the last milliliter (B) (see Mate-
rials and Methods). Note a delay in the elution of
trisialo- and tetrasialo-gangliosides on Sephadex G-25
columns when using the original method of Wells &
Dittmer. The ganglioside profile from CSF obtained by
our modification did not differ from the profile pro-
duced by microdialysis (see fig. 2). Ganglioside frac-
tions on HPTLC were visualized by spraying with re-
sorcinol/HCl reagent.
Fig. 3. HPTLC patterns of gangliosides from 5 ml CSF (0,
5 ml CSF + 5 μg GM2 (e) and after addition of pure
ganglioside extract from 5 ml CSF to 1 ml serum (g, h).
Note loss of polysialogangliosides after extraction of
samples with high protein content. Crude ganglioside
extracts were purified by microdialysis. Ganglioside
fractions on HPTLC were visualized by spraying with
resorcinol/HCl reagent.
a, b, c, d: 2.5, 5 and 7.5 μg of Cronassial gangliosides,
and 5 μg GM2 standard, respectively.
Bernheimer (4), Leeden & Yu (5), and Nagai et al. (6)
were the first to show that the TLC profile of CSF
gangliosides is similar to that of the brain. Naturally,
because of methodologic difficulties, these early chro-
matograms were of poor quality, or lacking certain
fractions.
In contrast to these results, Hirabayashi et al. (18)
have shown that GMi and GDia gangliosides predom-
inate in CSF, using a very sensitive method of enzyme-
immunostaining on the TLC plate. The reason for
the absence of the polysialogangliosides from the CSF
profile, may have been an inadequate procedure of
ganglioside extraction (chloroform/methanol alone,
without aqueous phase), leading to the loss of polar
gangliosides (9); or sialidase may have acted differ-
entially on particular types of gangliosides and con-
verted them into the corresponding asialolipids.
Comparison of brain and CSF ganglioside patterns
Parallel elution of the gangliosides of pooled 'normal"
CSF and of brain tissue from Sephadex G-25 columns
showed almost identical compositions, not only of the
major ganglioside fractions, but also of the fractions
designated as X,, X2 and X3. When a more polar
solvent system for HPTLC was used, chloroform-
methanol-12 mmol/1 MgCl2 in H2O- 13.3 mol/1 NH3
(56:44:9:0.5, by volume), the fractions designated
as X did not overlap with the major ganglioside
fractions and migrated between GDia and GDib (fig.
4). Unidentified Xi, X2 and X3 could be detected in
the composition of both brain and CSF gangliosides
and probably corresponded to GTia (Xi), GD2 (X2)
and GT3 (X3).
The data presented suggest that CSF contains gan-
gliosides that are nearly identical with typical brain
gangliosides. Therefore, CSF gangliosides are prob-
ably mostly secreted from brain cells, which appears
to be supported by the appearance of GM2 ganglioside
in the CSF of patients with GM2 gangliosidosis (3).
Content of CSF gangliosides in 'normal '
adults
Our results on the total content of gangliosides in ten
'normal' CSFs, i. e. 780 ± 82 μ§/1 of gangliosides
(tab. 3), is comparable to that reported by Ledeen &
Yu (466 — 1130 μg/l) (5). The presence of contaminants
(probably protein-bound NeuAc) might have been
responsible for the higher ganglioside value in normal
pooled CSF (1320 μg/l) reported by Nagai et al. (6).
Our method eliminates this effect, as the ganglioside
extract is first chromatographed on HPTLC, then
lipid-bound NeuAc is determined by densitometry.
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Fig. 4. Comparison of brain (B) and normal CSF (A) ganglioside HPTLC patterns after parallel elution, millilitre by m lilitre,
from Sephadex G-25 columns (eluates from three columns were combined). Note almost identical profiles, not only of
the major ganglioside fractions but also of those designated as Xl5 X2 and X3, probably corresponding to GTia, GD2 and
GTS- Ganglioside fractions on HPTLC were visualized by spraying with resorcinol/HCl reagent.
* Change of effluent polarity in the final millilitre (see Material and Methods)
In contrast, Hirabayashi et al. (18) used an enzyme-
immunostaining procedure to determine the concen-
tration of total ganglio-series gangliosides in CSF and
found it to be approximately 150 nmol/1. The mean
value of the ganglioside content in our study was 352
nmol/12), suggesting a loss of polysialogangliosides in
the procedure of Hirabayashi et al.
2) {GMi (16 nmol/1), GD3 (15 nmol/1), GDla (61 nmol/1), GDlb
(65 nmol/1), Gm (145 nmol/1) and GQlb (50 nmol/1)}, as
calculated by using the appropriate molecular mass of each
ganglioside.
Our method can therefore be used for the follow-up
and clinical evaluation of alterations in CSF ganglio-
sides in various neurologic diseases.
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